Can BioLine Rx Ltd’s Strategic Moves Revitalize Its Future in Biopharmaceutical Innovation?
BioLine Rx Ltd entered a strategic licensing agreement with AirMed Limited, securing a $10 million upfront and potential $87 million in milestones to extend its financial runway through 2026. The…